FDA-Drug2026-09-02Class IICHEMICAL

Accord Healthcare levothyroxine sodium 200 mcg tablets recalled for subpotency

LABEL MIX UPNationwide distributionDrugs

What this means

Accord Healthcare is recalling specific lots of levothyroxine sodium 200 mcg tablets because they contain less active ingredient than labeled. This means the medication may not work as intended for patients taking it to treat thyroid conditions.

  • Check your levothyroxine bottle for lot number D2402430, D2402431, D2402432, or D2500180 with expiration date 10/31/2026 or 12/31/2026.
  • If you have an affected lot, contact your pharmacy or doctor before stopping your medication.
  • Do not abruptly stop taking levothyroxine without guidance, as this can cause serious symptoms.
Get recalls like this in a free plain-English brief every Sunday.Get alerts ↓
The agency's original wording
Hazard

Subpotent Drug

Intended for
Adults
Illnesses reported
None reported
Sold states
Nationwide within the United States
Affected count
N/A
Manufactured in
8041 Arco Corporate Dr Ste 200, N/A, Raleigh, NC, United States
Products
Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg), packaged in a) 90-count bottles (NDC 16729-457-15) and b) 1000-count bottles (NDC 16729-457-17), Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India.

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0785-2026

More Accord Healthcare recalls

Want us to check the next one for you?

We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Free · One email a week · Unsubscribe anytime
By signing up you agree to our Terms and Privacy Policy.